These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 31592585)

  • 21. New antibiotic agents: problems and prospects.
    Weber DJ; Rutala WA
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-97-107. PubMed ID: 23577500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Microbiological profiles of pathogens causing nosocomial bacteremia in 2011, 2013 and 2016].
    Wang X; Zhao C; Li H; Chen H; Jin L; Wang Z; Liao K; Zeng J; Xu X; Jin Y; Su D; Liu W; Hu Z; Cao B; Chu Y; Zhang R; Luo Y; Hu B; Wang H
    Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1205-1217. PubMed ID: 30152206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting.
    Navon-Venezia S; Ben-Ami R; Carmeli Y
    Curr Opin Infect Dis; 2005 Aug; 18(4):306-13. PubMed ID: 15985826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial resistance in internal medicine wards.
    Menichetti F; Tagliaferri E
    Intern Emerg Med; 2012 Oct; 7 Suppl 3():S271-81. PubMed ID: 23073868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
    Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA
    Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic membrane-targeted antibiotics.
    Vooturi SK; Firestine SM
    Curr Med Chem; 2010; 17(21):2292-300. PubMed ID: 20459377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergence of high drug resistant bacterial isolates from patients with health care associated infections at Jimma University medical center: a cross sectional study.
    Gashaw M; Berhane M; Bekele S; Kibru G; Teshager L; Yilma Y; Ahmed Y; Fentahun N; Assefa H; Wieser A; Gudina EK; Ali S
    Antimicrob Resist Infect Control; 2018; 7():138. PubMed ID: 30479751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro synergistic effect of the CM11 antimicrobial peptide in combination with common antibiotics against clinical isolates of six species of multidrug-resistant pathogenic bacteria.
    Amani J; Barjini KA; Moghaddam MM; Asadi A
    Protein Pept Lett; 2015; 22(10):940-51. PubMed ID: 26216264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacterial and fungal pathogens isolated from patients with bloodstream infection: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (2012-2017).
    Pfaller MA; Carvalhaes CG; Smith CJ; Diekema DJ; Castanheira M
    Diagn Microbiol Infect Dis; 2020 Jun; 97(2):115016. PubMed ID: 32111415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacterial Epidemiology and Antimicrobial Resistance Profiles in Children Reported by the ISPED Program in China, 2016 to 2020.
    Fu P; Xu H; Jing C; Deng J; Wang H; Hua C; Chen Y; Chen X; Zhang T; Zhang H; Chen Y; Yang J; Lin A; Wang S; Cao Q; Wang X; Deng H; Cao S; Hao J; Gao W; Huang Y; Yu H; Wang C
    Microbiol Spectr; 2021 Dec; 9(3):e0028321. PubMed ID: 34730410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial activities and membrane-active mechanism of CPF-C1 against multidrug-resistant bacteria, a novel antimicrobial peptide derived from skin secretions of the tetraploid frog Xenopus clivii.
    Xie J; Gou Y; Zhao Q; Wang K; Yang X; Yan J; Zhang W; Zhang B; Ma C; Wang R
    J Pept Sci; 2014 Nov; 20(11):876-84. PubMed ID: 25098547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent against Multidrug-Resistant Bacteria in a Murine Model of Sepsis.
    Lee HR; You DG; Kim HK; Sohn JW; Kim MJ; Park JK; Lee GY; Yoo YD
    mBio; 2020 Apr; 11(2):. PubMed ID: 32291307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Mortality Burden of Multidrug-resistant Pathogens in India: A Retrospective, Observational Study.
    Gandra S; Tseng KK; Arora A; Bhowmik B; Robinson ML; Panigrahi B; Laxminarayan R; Klein EY
    Clin Infect Dis; 2019 Aug; 69(4):563-570. PubMed ID: 30407501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of methicillin resistant
    Upreti N; Rayamajhee B; Sherchan SP; Choudhari MK; Banjara MR
    Antimicrob Resist Infect Control; 2018; 7():121. PubMed ID: 30338059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment options for multidrug-resistant bacteria.
    Giamarellou H
    Expert Rev Anti Infect Ther; 2006 Aug; 4(4):601-18. PubMed ID: 17009940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.
    Medina E; Pieper DH
    Curr Top Microbiol Immunol; 2016; 398():3-33. PubMed ID: 27406189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
    Decousser JW; Woerther PL; Soussy CJ; Fines-Guyon M; Dowzicky MJ
    Antimicrob Resist Infect Control; 2018; 7():68. PubMed ID: 29876099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of COVID-19 pandemic on multidrug resistant gram positive and gram negative pathogens: A systematic review.
    Abubakar U; Al-Anazi M; Alanazi Z; Rodríguez-Baño J
    J Infect Public Health; 2023 Mar; 16(3):320-331. PubMed ID: 36657243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial activities and action mechanism studies of transportan 10 and its analogues against multidrug-resistant bacteria.
    Xie J; Gou Y; Zhao Q; Li S; Zhang W; Song J; Mou L; Li J; Wang K; Zhang B; Yang W; Wang R
    J Pept Sci; 2015 Jul; 21(7):599-607. PubMed ID: 25891396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antimicrobial treatment of nosocomial intra-abdominal infections--new treatment options with tygecycline].
    Vyhnánek F; Adámková V; Duchác V; Teplan V; Jirásek T
    Rozhl Chir; 2009 Sep; 88(9):503-7. PubMed ID: 20052927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.